AD-sEV not cross-reactive immune responses against tumor cells mediates inhibitory effects of hAEC. »
10/29/22

HIPEC at CRS for EOC appears to depend on timing. »
08/02/22

PHS290 remained strong independent predictor of any, metastatic, and fatal prostate cancer. »
04/11/22

Patients with stage IVA showed significantly better OS than those with stage IVB disease. »
07/29/22

Percentage tumor reduction to be good predictor of histological therapeutic effect. »
09/04/22

Three differentially expressed genes, ARHGAP4, NOS3, and OR51B5, identified. »
09/06/22

Multivariable regression models showed racial/ethnic differences in predictors of CCS. »
10/26/22

Subset analysis showed that chromium is potential biomarker for luminal subtype. »
08/25/22

Risk models provide new insights into predicting prognosis, tumor invasion, and metastasis. »
07/15/22

Neutropenia and neurotoxicity most frequent severe AEs. »
10/28/22